These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3796800)

  • 1. Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonists.
    Blackshear MA; Martin LL; Sanders-Bush E
    Neuropharmacology; 1986 Nov; 25(11):1267-71. PubMed ID: 3796800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of 5-HT(2A) receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin.
    Anji A; Kumari M; Sullivan Hanley NR; Bryan GL; Hensler JG
    Neuropharmacology; 2000 Aug; 39(11):1996-2005. PubMed ID: 10963743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin receptor sensitivity after acute and chronic treatment with mianserin.
    Blackshear MA; Sanders-Bush E
    J Pharmacol Exp Ther; 1982 May; 221(2):303-8. PubMed ID: 7077527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single or repeated administrations of SCH 23390 fail to affect serotonergic neurotransmission.
    Gandolfi O; Roncada P; Dall'Olio R
    Neurosci Lett; 1988 Oct; 92(2):192-6. PubMed ID: 2460808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol.
    Alexander BS; Wood MD
    J Pharm Pharmacol; 1987 Aug; 39(8):664-6. PubMed ID: 2888864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice.
    Goodwin GM; Green AR; Johnson P
    Br J Pharmacol; 1984 Sep; 83(1):235-42. PubMed ID: 6237705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.
    Peroutka SJ
    J Neurochem; 1986 Aug; 47(2):529-40. PubMed ID: 2942638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the rat brain 5-HT1A and 5-HT2 receptors after chronic administration of levoprotiline, (+)-oxaprotiline and other antidepressant drugs.
    Klimek V; Zak-Knapik J; Cannizzaro C
    Pol J Pharmacol Pharm; 1992; 44(6):549-60. PubMed ID: 1305956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
    Ferry RC; Unsworth CD; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic mianserin administration on serotonin metabolism and receptors in the 5-hydroxytryptophan depression model.
    Akiyoshi J; Tsuchiyama K; Mizobe Y; Nakamura M; Kuranaga H; Nagayama H
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):165-79. PubMed ID: 7509496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual acute effects of antidepressants and neuroleptics on S2-serotonergic receptors.
    Helmeste DM; Tang SW
    Life Sci; 1983 Dec; 33(25):2527-33. PubMed ID: 6139734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of repeated trazodone administrations on serotonergic neurotransmission: biochemical studies.
    Gandolfi O; Roncada P; Dall'Olio R
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):941-52. PubMed ID: 2554363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF; Arora RC; Schreiber MA; Meltzer HY
    Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT2 receptors, roles and regulation.
    Leysen JE; Pauwels PJ
    Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats.
    Lund A; Mjellem N
    Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.